That study was led by Dr Hahn, who was originally skeptical about the DurAVR's benefit but was literally giddy with excitement talking about the valve in the recent TCT panel video.
- Forums
- ASX - By Stock
- Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
AVR
anteris technologies global corp.
Add to My Watchlist
0.50%
!
$6.00

That study was led by Dr Hahn, who was originally skeptical...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.00 |
Change
-0.030(0.50%) |
Mkt cap ! $92.99M |
Open | High | Low | Value | Volume |
$6.01 | $6.03 | $5.84 | $85.53K | 14.32K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 333 | $6.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.25 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 333 | 6.000 |
1 | 497 | 5.980 |
1 | 874 | 5.970 |
1 | 50000 | 5.950 |
1 | 25 | 5.850 |
Price($) | Vol. | No. |
---|---|---|
6.250 | 1000 | 1 |
6.550 | 1092 | 1 |
6.600 | 320 | 1 |
6.650 | 100 | 1 |
6.910 | 1000 | 1 |
Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |